by Carolyn Helms | May 30, 2025
CytomX Therapeutics (NASDAQ: CTMX) is a clinical-stage biotechnology company developing novel conditionally activated, masked biologics designed to be localized to the tumor microenvironment. 
by Carolyn Helms | May 12, 2025
Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity. 
by Carolyn Helms | Jan 16, 2025
Aviceda Therapeutics is a biotechnology company developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform to alleviate chronic, non-resolving inflammation. 
by Carolyn Helms | Dec 15, 2024
Veradermics (NYSE: MANE) is a clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions. 
by Carolyn Helms | Nov 15, 2024
Alentis Therapeutics is a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis.